Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.8400
+0.0012 (0.14%)
At close: Sep 26, 2025, 4:00 PM EDT
0.8215
-0.0185 (-2.20%)
After-hours: Sep 26, 2025, 7:56 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $69.93 million as of September 26, 2025. Its market cap has decreased by -40.65% in one year.
Market Cap
69.93M
Enterprise Value
-39.67M
1-Year Change
-40.65%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $69.93M, a decrease of -76.82%. That is a compound annual growth rate of -25.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 69.93M | -11.78% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 649.36B |
| Johnson & Johnson | 424.86B |
| AbbVie | 386.23B |
| UnitedHealth Group | 312.93B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 229.43B |